Pfizer: what’s next for the Covid-19 vaccine maker and its US$28 billion war chest?

Coronavirus pandemic: All stories

  • Pfizer’s vaccine saw it become the world’s most visible pharmaceutical company, but with its stock falling in 2022, investors are impatient for an encore

READ FULL ARTICLE